FindTrial
Sign In

PREVALENCE OF ANTIPHOSPHOLIPID ANTIBODY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT AND ITS CORRELATION WITH ORGAN INVOLVEMENT.

Prevalence of antiphospholipid antibody in sle patient and its correlation with organ involvement - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/098020
Enrollment
50
Registered
2025-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D808- Other immunodeficiencies with predominantly antibody defects

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Dr Saurabh Modi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All indoor and outdoor patients with sle presenting to DY PATIL MEDICAL COLLEGE Pregnancy APLA POSITIVE STATUS ANA POSITIVE STATUS Newly and already diagnosed case of SLE

Exclusion criteria

Exclusion criteria: Patients unwilling for study Patients with age less than 15 years

Design outcomes

Primary

MeasureTime frame
Evaluate patients presenting with SLE TO Determine clinical phenotype or analysis of clinical and serological characteristics in APLA positive SLE patientTimepoint: 1 year—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Saurabh Modi

Dr DY PATIL MEDICAL COLLEGE

drjoshimanohar@gmail.com9022777731

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026